Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
4572.T Stock Summary
Top 10 Correlated ETFs
4572.T
In the News
4572.T Financial details
Company Rating
Buy
Market Cap
12.63B
Income
-1.85B
Revenue
1.06B
Book val./share
277.65
Cash/share
257.72
Dividend
-
Dividend %
-
Employees
65
Optionable
No
Shortable
Yes
Earnings
03 Aug 2023
P/E
-6.33
Forward P/E
-
PEG
13.95
P/S
11.93
P/B
2.67
P/C
2.88
P/FCF
-
Quick Ratio
10.48
Current Ratio
12.31
Debt / Equity
0.12
LT Debt / Equity
0.03
-
-
EPS (TTM)
-40.19
EPS next Y
-
EPS next Q
-
EPS this Y
135.39%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-4.54%
Revenue last 5Y
12.94%
Revenue Q/Q
-22.04%
EPS Q/Q
-
-
-
-
-
SMA20
17.74%
SMA50
58.38%
SMA100
40.39%
Inst Own
-
Inst Trans
-
ROA
-37%
ROE
-45%
ROC
-0.39%
Gross Margin
83%
Oper. Margin
-168%
Profit Margin
-175%
Payout
-
Shs Outstand
17.05M
Shs Float
13.85M
-
-
-
-
Target Price
-
52W Range
447.0-984.0
52W High
-24.7%
52W Low
+65.77%
RSI
54.17
Rel Volume
1.06
Avg Volume
832.47K
Volume
882.1K
Perf Week
-3.14%
Perf Month
47.9%
Perf Quarter
-1.07%
Perf Half Y
-5.24%
-
-
-
-
Beta
1.54584
-
-
Volatility
20.2%, 78.72%
Prev Close
-0.94%
Price
741
Change
-8.86%
4572.T Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 77.94 | 294.51 | 92.15 | 158.92 | 101.84 | |
Net income per share | -125.02 | 76.05 | -90.33 | -42.1 | -99.1 | |
Operating cash flow per share | -116.49 | 135.69 | -102.53 | -121.04 | -52.02 | |
Free cash flow per share | -122.52 | 131.83 | -108.12 | -124.32 | -61.27 | |
Cash per share | 139.96 | 451.31 | 349.55 | 300.72 | 248.14 | |
Book value per share | 91.65 | 353.84 | 310.92 | 339.93 | 267.44 | |
Tangible book value per share | 91.65 | 353.84 | 310.92 | 339.93 | 267.44 | |
Share holders equity per share | 91.65 | 353.84 | 310.92 | 339.93 | 267.44 | |
Interest debt per share | 72 | 67.67 | 35.54 | 42.83 | 22.45 | |
Market cap | 8.71B | 23.12B | 14.91B | 13.99B | 7.08B | |
Enterprise value | 8.05B | 18.93B | 11.04B | 10.71B | 4B | |
P/E ratio | -7.2 | 27.91 | -13.42 | -26.18 | -5.25 | |
Price to sales ratio | 11.55 | 7.21 | 13.15 | 6.93 | 5.11 | |
POCF ratio | -7.73 | 15.65 | -11.82 | -9.1 | -10 | |
PFCF ratio | -7.35 | 16.1 | -11.21 | -8.86 | -8.49 | |
P/B Ratio | 9.82 | 6 | 3.9 | 3.24 | 1.94 | |
PTB ratio | 9.82 | 6 | 3.9 | 3.24 | 1.94 | |
EV to sales | 10.66 | 5.9 | 9.74 | 5.31 | 2.89 | |
Enterprise value over EBITDA | -6.8 | 19.43 | -10.44 | -21.43 | -3.22 | |
EV to operating cash flow | -7.13 | 12.81 | -8.75 | -6.97 | -5.65 | |
EV to free cash flow | -6.78 | 13.19 | -8.3 | -6.79 | -4.8 | |
Earnings yield | -0.14 | 0.04 | -0.07 | -0.04 | -0.19 | |
Free cash flow yield | -0.14 | 0.06 | -0.09 | -0.11 | -0.12 | |
Debt to equity | 0.99 | 0.4 | 0.26 | 0.26 | 0.17 | |
Debt to assets | 0.5 | 0.28 | 0.21 | 0.21 | 0.15 | |
Net debt to EBITDA | 0.57 | -4.29 | 3.66 | 6.56 | 2.48 | |
Current ratio | 4.18 | 5 | 6.47 | 6.87 | 9.4 | |
Interest coverage | -107.69 | 119.77 | -143.37 | -135.32 | -239.15 | |
Income quality | 0.93 | 1.62 | 1.14 | 2.89 | 0.54 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0.05 | -0.03 | 0.05 | 0.03 | 0.18 | |
Capex to revenue | -0.08 | -0.01 | -0.06 | -0.02 | -0.09 | |
Capex to depreciation | -4.59 | -4.47 | -5.55 | -2.17 | -3.73 | |
Stock based compensation to revenue | 0 | 0.01 | 0.05 | 0.03 | 0.04 | |
Graham number | 507.74 | 778.14 | 794.95 | 567.44 | 772.24 | |
ROIC | 1.22 | -0.2 | 0.28 | 0.24 | 0.52 | |
Return on tangible assets | -0.68 | 0.15 | -0.23 | -0.1 | -0.32 | |
Graham Net | 54.53 | 316.02 | 271.57 | 217.09 | 206.63 | |
Working capital | 1.27B | 4.22B | 3.98B | 4.54B | 3.67B | |
Tangible asset value | 887.45M | 3.85B | 3.82B | 4.31B | 3.64B | |
Net current asset value | 788.95M | 3.75B | 3.7B | 4.2B | 3.48B | |
Invested capital | 0.77 | 0.19 | 0.11 | 0.13 | 0.08 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 1.75M | 1.83M | 2.35M | 1.91M | 2.13M | |
Average inventory | 114.37M | 105.1M | 101.97M | 107.51M | 114.51M | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0.7 | 5.58 | 2.88 | 6.18 | 4.17 | |
Days of inventory on hand | 161.29 | 174.8 | 198.55 | 297.87 | 252.19 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 524.47 | 65.42 | 126.66 | 59.02 | 87.44 | |
Inventory turnover | 2.26 | 2.09 | 1.84 | 1.23 | 1.45 | |
ROE | -1.36 | 0.21 | -0.29 | -0.12 | -0.37 | |
Capex per share | -6.02 | -3.86 | -5.6 | -3.28 | -9.25 |
Quarterly Fundamentals Overview
Last date of statement is 2023-03-31 for Q1
Metric | History | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 |
---|---|---|---|---|---|---|
Revenue per share | 41.23 | 2.71 | 2.43 | 0 | 14.33 | |
Net income per share | -1.12 | -3.27 | -4.14 | 0 | -32.78 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 362.63 | 44.52 | 35.43 | 0 | 257.72 | |
Book value per share | 337.57 | 42.07 | 37.48 | 0 | 277.65 | |
Tangible book value per share | 337.57 | 42.07 | 37.48 | 0 | 277.65 | |
Share holders equity per share | 337.57 | 42.07 | 37.48 | 0 | 277.65 | |
Interest debt per share | 34.76 | 3.87 | 3.17 | 0 | 16.24 | |
Market cap | 14.1B | 94.69B | 89.96B | 0 | 7.52B | |
Enterprise value | 9.68B | 90.42B | 86.56B | -3.08B | 3.7B | |
P/E ratio | -233.33 | -68.82 | -51.57 | 0 | -3.62 | |
Price to sales ratio | 25.42 | 332.39 | 351.32 | 0 | 33.15 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 3.1 | 21.4 | 22.81 | 0 | 1.71 | |
PTB ratio | 3.1 | 21.4 | 22.81 | 0 | 1.71 | |
EV to sales | 17.46 | 317.37 | 338.06 | -10.57 | 16.29 | |
Enterprise value over EBITDA | 2.25K | -293.87 | -202.3 | 5.66 | -7.22 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | 0 | 0 | 0 | 0 | -0.07 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0.18 | 0.18 | 0.15 | 0.17 | 0.12 | |
Debt to assets | 0.15 | 0.15 | 0.13 | 0.15 | 0.11 | |
Net debt to EBITDA | -1.02K | 13.91 | 7.94 | 5.66 | 7.47 | |
Current ratio | 10.49 | 10.43 | 11.8 | 9.4 | 12.31 | |
Interest coverage | 8.94 | -219.14 | -363.53 | -500.18 | -564.5 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 92.35 | 55.63 | 59.12 | 0 | 452.53 | |
ROIC | 0 | 0.08 | 0.15 | 0.21 | 0.16 | |
Return on tangible assets | 0 | -0.07 | -0.1 | -0.13 | -0.11 | |
Graham Net | 306.26 | 37.53 | 30.24 | 0 | 227.47 | |
Working capital | 4.75B | 4.57B | 4B | 3.67B | 4.41B | |
Tangible asset value | 4.54B | 4.42B | 3.94B | 3.64B | 4.4B | |
Net current asset value | 4.44B | 4.27B | 3.76B | 3.48B | 4.25B | |
Invested capital | 0.1 | 0.09 | 0.08 | 0.08 | 0.06 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 1.57M | 665K | 1.86M | 2.6M | 2M | |
Average inventory | 111.47M | 112.82M | 114.93M | 117.6M | 127.69M | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 1.8 | 1.06 | 7.19 | 3.69 | 3.76 | |
Days of inventory on hand | 238.23 | 250.92 | 258.65 | 222.82 | 253.22 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 49.98 | 84.57 | 12.53 | 24.4 | 23.96 | |
Inventory turnover | 0.38 | 0.36 | 0.35 | 0.4 | 0.36 | |
ROE | 0 | -0.08 | -0.11 | -0.15 | -0.12 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
4572.T Frequently Asked Questions
What is Carna Biosciences, Inc. stock symbol ?
Carna Biosciences, Inc. is a JP stock and trading under the symbol 4572.T
What is Carna Biosciences, Inc. stock quote today ?
Carna Biosciences, Inc. stock price is $741 today.
Is Carna Biosciences, Inc. stock public?
Yes, Carna Biosciences, Inc. is a publicly traded company.